Isolation and identification of impurities in chlorin e6

Area of Science:

• Pharmaceutical Chemistry
• Organic Chemistry
• Photodynamic Therapy

Background:

• Chlorin e6 is a tetrapyrrolic compound used in Photolon for photodynamic therapy.
• Impurities in chlorin e6 can originate from manufacturing processes and degradation.
• Understanding these impurities is crucial for drug quality and efficacy.

Purpose of the Study:

• To identify and characterize the main impurities present in chlorin e6.
• To elucidate the formation pathways of these impurities during production and storage.

Main Methods:

• Preparation of impurities via liquid extraction, preparative chromatography, and chemical synthesis.
• Identification using High-Performance Liquid Chromatography with Photodiode Array Detection and Mass Spectrometry (HPLC-PDA-MS).
• Structural elucidation through 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy.

Main Results:

• Identified ten major impurities including chlorin e6 17(4)-ethyl ester, chlorin e4, 15-hydroxyphyllochlorin, rhodochlorin, and various rhodochlorin and rhodoporphyrin derivatives.
• Established the structures of these process- and degradation-related impurities.
• Discussed potential formation routes for the identified chlorin derivatives.

Conclusions:

• The study successfully identified key impurities in chlorin e6, crucial for pharmaceutical applications.
• Understanding impurity profiles aids in optimizing production and storage conditions for chlorin e6.
• This research contributes to the quality control and safety of photodynamic therapy agents.